ITGA2 and colorectal cancer: In line with the observed targeting of ITGA2 3′ UTR by miR-324-5p targets, miR-324-5p knock-down or forced over-expression of ITGA2 has reduced the impact of VPS9D1-AS1 silencing in colorectal cancer cells.